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Abstract. Endomannosidase is a Golgi-localized en-
doglycosidase, which provides an alternate glucosi-
dase-independent pathway of glucose trimming.
Using a protease protection assay we demonstrated
that Golgi-endomannosidase is a type II membrane
protein. The first 25 amino acids of this protein,
containing the cytoplasmic tail and the transmem-
brane domain, were sufficient for Golgi retention of
fused reporter proteins a1-antitrypsin or green fluo-
rescent protein. However, shortening or deletion of
the transmembrane domain prevented Golgi local-
ization, while lengthening it partially reduced Golgi
retention of the enzyme. Substitution of the highly
conserved positively charged amino acids within the
cytoplasmic tail had neither an effect on type II
topology nor on the inherent Golgi localization of the
enzyme. In contrast, cytoplasmic tail-deleted rat
endomannosidase possessed an inverted topology
resulting in endoplasmic reticulum mislocalization.
Thus, proper topology rather than the presence of
positively charged amino acids in the cytoplasmic tail
is critical for Golgi localization of rat endomannosi-
dase.
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Introduction
Newly synthesized proteins contain targeting signals
consisting of short discrete amino acid sequence
motifs that direct them to distinct compartments
within the cell. Such sequences within proteins were
identified for their targeting or retention in endo-
somes, lysosomes and endoplasmic reticulum (ER)
(for review see [1–3]).
Various signals for retention and/or retrieval in theER
have been identified. Type I membrane proteins are
retained in the ER by a di-lysine motif correctly
positioned relative to the C terminus [4–7], whereas
an N-terminal double arginine motif in the cytoplas-
mic tail of type II membrane proteins might serve as
ER targeting signal [8].On the other hand, solubleER
proteins containing the C-terminal KDEL/HDEL
tetrapeptide [9, 10] are efficiently retrieved from the
Golgi to the ER by the KDEL receptor [11]. Prior to
ER retrieval via a retrograde transport route, these
proteins receive a Golgi-associated post-translational
modification [6, 12].
Various glycosidases and glycosyltransferases are
localized in distinct partially overlapping subcompart-
ments of the Golgi apparatus [13] possessing a type II
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membrane architecture [14]. Although they share a
common domain structure, no specific targeting
signals for Golgi localization could be identified.
There is evidence that not only the transmembrane
domain but also the cytoplasmic and/or luminal
sequences play a role for Golgi retention [15–19].
Furthermore, cell type-related variability has been
observed for the same Golgi enzyme in regard to the
role of domains for retention [20]. Two models have
been proposed to explain Golgi retention. In the kin
recognition model [21], it was suggested that Golgi
enzymes interact with each other forming large
hetero-oligomeric structures that are too large to
enter transport vesicles. In the lipid bilayer model, the
hydrophobic transmembrane region is proposed to
retain the enzyme in the Golgi apparatus [15].
Endomannosidase represents a unique endoglycosi-
dase in the cis andmedialGolgi apparatus [22, 23] and
provides there an alternate glucosidase-independent
glucose-trimming pathway. The mechanism by which
the enzyme is retained in the Golgi apparatus is
currently unknown. Cloning of endomannosidase
[24–26] revealed a high interspecies amino acid
sequence identity [26]. Endomannosidases share
particular features, i.e. , three consecutive positively
charged amino groups close to the N terminus fol-
lowed by a single stretch of hydrophobic amino acids
(residues 10–25) and conserved amino acid regions
close to the C terminus [26]. It is not known whether
the hydrophobic region is part of an uncleavable 25-
amino acid signal sequence and functions as a
membrane-spanning domain resulting in a type II
membrane protein topology. Alternatively, a soluble
enzyme could be generated by a cleavable signal
sequence or if one of the two conserved methionine
residues at position 23 and 24 [26] serves as an
alternative translation start.
In this study, we report the molecular architecture of
endomannosidase and demonstrate that both its
cytoplasmic and transmembrane domains are re-
quired for its efficient Golgi localization. Further-
more, we demonstrate that the positively charged
amino acids in the cytoplasmic tail are not essential for
type II membrane topology of the enzyme.
Materials and methods
Materials. Rabbit anti-human Sec61b antibody was
kindly provided by Dr. B. Dobberstein (University of
Heidelberg, Heidelberg, Germany) and rabbit anti-
Golgi mannosidase II antibody by K. Moremen
(Complex Carbohydrate Research Center, Athens,
GA). Rabbit anti-human a1-antitrypsin antibody was
purchased from Dako (Zug, Switzerland). The mouse
monoclonal anti-myc antibody was from Upstate
(Milton Keynes, UK). Rabbit anti-green fluorescent
protein (GFP), rhodamine-conjugated F(ab’)2 frag-
ments of goat anti-rabbit IgG and Alexa 488-conju-
gated F(ab’)2 fragments of goat anti-mouse IgG were
from Molecular Probes (Eugene, OR). Horseradish
peroxidase-conjugated goat anti-rabbit IgG and goat
anti-mouse IgG were purchased from Jackson Immu-
noResearch Laboratories, Inc. (West Grove, PA,
USA).
Restriction enzymes, T4DNA ligase, endoglycosidase
H (Endo H), recombinant N-glycosidase F (PNGase
F) and protease inhibitor tablets were purchased from
Roche Diagnostics (Rotkreuz, Switzerland), Taq
DNA polymerase, expression vectors pcDNA3.1,
pcDNA6/myc-His, pEGFP vector, competent E. coli
DH5a cells, Lipofectamine 2000, cell culture media
and fetal bovine serum from Invitrogen (Basel,
Switzerland) and QIAquick PCR-purification Kit
from Qiagen (Basel, Switzerland). Oligonucleotides
were synthesized by Microsynth (Balgach, Switzer-
land).
Recombinant DNAs. For chimeric a1-antrypsin
(rEndo25/A1AT, Fig. 1A) the signal sequence of
human a1-antitrypsin comprising the amino acids
1–24 was replaced with the DNA fragment encoding
the 25 amino acids of the putative signal sequence of
rat endomannosidase using PCR amplification. Full-
length rat endomannosidase subcloned in the expres-
sion vector pcDNA6 [27] served as template in
combination with the corresponding sense/antisense
oligonucleotides (Table 1).
For construction of rat endomannosidase with trun-
cations in the signal sequence (Fig. 1B and C), or the
replacement of the transmembrane domain by poly-
leucines (Fig. 1A) as well as for constructs containing
mutations in the cytoplasmic tail (Fig. 1D) full-length
rat endomannosidase cDNA in pcDNA6 vector [27]
was used as template in the PCR amplification in
combination with the corresponding sense/antisense
oligonucleotides (Table 1). The corresponding PCR
products were either subcloned into the HindIII/
Xho I site of the pcDNA6 vector in frame with the
myc-tag or into the Hind III/Bam HI site of the
pEGFP vector for rat endomannosidase25. The cor-
rectness of each construct was verified by DNA-
sequencing.
Cell lines and transfections. Clone 9 hepatocytes,
CHO-K1, HepG2 and HeLa cells were obtained from
American Type Culture Collection (Manassas, VA)
and cultured in Hams F12 medium with 10% FBS.
Transfections of various cell lines with different
constructs were performed using Lipofectamine
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2000 and Opti-MEM medium according to the
manufacturers instructions and selected in medium
containing the appropriate antibiotic. Clonal cell lines
were obtained from transfected cells by limiting
dilution.
Immunoprecipitation of metabolically labeled chi-
meric a1-antitrypsin and Endo H treatment. For
metabolic labeling of transfected clone 9 hepatocytes,
[35S]methionine (100 mCi/ml) and methionine-free
DMEM was used. Clone 9 hepatocytes were chased
at indicated time points and cells were lysed in PBS
containing 1%Triton X-100 and protease inhibitors.
Chimeric a1-antitrypsin was immunoprecipitated
from cell lysates and media and analyzed in 8%
SDS-polyacrylamide gels. Immunoprecipitated chi-
meric a1-antrypsin from cell lysates was treated with
Endo H and PNGase F as previously described [27].
Radioactivity was visualized by fluorography after
treatment with EN3HANCER using X-Omatic AR
film.
Protease protection assay and Western blot analysis.
CHO-K1 cells expressing myc-tagged rat endoman-
nosidase or rat endomannosidase25-GFP were homo-
genized in 250 mM sucrose, 10 mM Tris-HCl pH 7.4
and centrifuged at 100 000 g for 1 h at 48C. Mem-
branes were incubated with 2.5 M urea on ice for
30 min and centrifuged as described above. Proteins of
the pellet and supernatant were analyzed in 10%
SDS-polyacrylamide gels and subjected to Western
blot analysis. For protease protection assay, urea-
stripped membranes were treated with proteinase K
(0.2 or 2 mg) in the absence or presence of 1% Triton
X-100. The reaction was stopped by the addition of
trichloroacetic acid (TCA). The TCA-precipitated
proteins were analyzed in 10% and 12% SDS-
polyacrylamide gels, respectively, transferred onto
nitrocellulose membranes using a semidry blotting
apparatus [28]. The nitrocellulose membranes were
blocked in PBS containing 1%BSA for 1 h at ambient
temperature and incubated with mouse anti-myc
antibody and rabbit anti-GFP antibody, respectively,
overnight at 48C followed by the incubation with the
corresponding horseradish-conjugated secondary an-
tibody for enhanced chemiluminescence detection.
Western blot analysis of CHO-K1 cells expressing
rEndo25, 23, 21–9-GFP constructs was performed. CHO-
Table 1. Oligonucleotides used for the generation of chimeric a1-antitrypsin (A1AT), and GFP constructs and various rat
endomannosidase mutantsa.
Primer 5’-3’ sequence
Chimeric-A1AT (s) TAGAAGCTTGTCATCATGGCAAAATTCCGAAGAAGGACCTGCAT
Chimeric-A1AT (as) GGATCCTCTAAGCCCATCATCAGAGAGAAA
rEndo23-GFP (as) GGATCCCATCAGAGAGAAAAT
rEndo21-GFP (as) GGATCCAGAGAAAATAAATAC
rEndo19-GFP(as) GGATCCAATAAATACAATAAA
rEndo17-GFP (as) GGATCCTACAATAAAAAGTGA
rEndo15-GFP (as) GGATCCAAAAAGTGACAAAAT
rEndo13-GFP (as) GGATCCAAAAGTGACAAAAT
rEndo11-GFP (as) GGATCCAATGATGCAGGTCCT
rEndo9-GFP (s) AGCTTGTCATCATGGCAAAATTCCGAAGAAGGACCTGCG
rEndo9-GFP (as) GATCCGCAGGTCCTTCTTCGGAATTTTGCCATGATGACA
Dsig-rEndo (s) TAGAAGCTTGTCATCATGGCAAAATTCCGAAGAAGGACCTGCAT
DCT-rEndo (s) AAGCTTGTCATCATGATCATTTTGTCACTTTTTATTGTATTTATTTTCT
DTMD-rEndo (s) AAGCTTGTCATCATGGCAAAATTCCGAAGAAGGACCTGCTTAAAGATGCTGTGG
rEndo DTMD/L16 TAGAAGCTTGTCATCATGGCAAAATTCCGAAGAAGGACCTGCCTCCTCCTGCTGTTGCTTTTGC
TCCTGCCCTGCTTCTTCTGCTGCTCTTAAAGATGCTGTGGCC
rEndo DTMD/L23 TAGAAGCTTGTCATCATGGCAAAATTCCGAAGAAGGACCTGCCTCCTCCTGCTGTTGCTTTTGC
TCCTGCTCCTGCTTCTTCTGCTGCTCCTCTTGCTACTGCTTCTCCTCTTAAAGATGCTGTGG
rEndo R5–7K (s) AAGCTTGTCATCATGGCAAAATTCAAGAAAAAGACCTGCATCATTTTGTCACT
MRRR-rEndo (s) TAGAAGCTTGTCATCATGCGAAGAAGGACCTGC
MLLL-rEndo (s) TAGAAGCTTGTCATCATGCTACTGCTGACCTGC
rEndo (as) TCTCGAGCGAAGCAGGCAGCTGTTGATCC
aRecognition sites of restriction enzymes are given in bold; startmethionine is underlined; replaced nucleotides are in italics. (s) sense; (as)
antisense oligonucleotide.
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K1 cells were homogenized and separated into a
membrane and cytosolic fraction by differential
centrifugation. Proteins were analyzed in 12% SDS-
polyacrylamide gels and subjected to Western blot
analysis using a rabbit anti-GFP antibody (2 mg/ml) in
combination with the corresponding horseradish-
conjugated secondary antibody.
Confocal immunofluorescencemicroscopy.Transfect-
ed CHO-K1 cells grown as monolayer on glass cover
slips were formaldehyde-fixed and saponin-permea-
bilized. Single (for a1-antitrypsin and for Man II,
respectively) and double (myc and Man II or sec61b ;
a1-antitrypsin and Man II, respectively) immunolab-
eling incubations were performed as described [26].
Immunofluorescence was observed with Leica Con-
focal Laser Scanning Microscopes SP2 and SL2 using
the 100 objective (1.4). In double-immunofluores-
cence overlays, effects of z axis pixel shifts were
corrected.
Results
Rat endomannosidase is a type II membrane protein.
Endomannosidase is located in cis and medial Golgi
cisternae and to lesser amounts in pre-Golgi inter-
mediates [23]. We have aimed to establish the
molecular architecture of the enzyme and to identify
putative Golgi retention targeting sequences. By
stably expressing a myc-tagged rat endomannosidase
(rEndo) in CHO-K1 cells, we observed that the
enzyme behaved as a membrane-bound protein.
Western blot analysis of CHO-K1 cell membranes,
treated with urea to release membrane-associated
proteins, showed twomajor anti-myc immunoreactive
species in the membrane fraction, due to Golgi-
associated post-translational modifications [26] and
none in the supernatant (Fig. 2A). To obtain informa-
tion about its membrane orientation, we determined
sensitivity of endomannosidase against proteinase K.
Treatment of CHO-K1 cell membranes with protei-
nase K did not alter rEndo, whereas Triton X-100
Figure 1. Schematic representation of various rat endomannosidase constructs used for transfections. (A) Myc-tagged rat endomanno-
sidase with its putative signal sequence consisting of the cytoplasmic tail (CT) and the transmembrane domain (TMD) as well as the large
luminal domain. The rat endomannosidase signal sequence was fused either to human a1-antitrypsin (A1AT) or to green fluorescent
protein (GFP). Alternatively, the transmembrane domain of rEndo was completely replaced by poly-leucine, L16 and L23, respectively. (B)
The length of the transmembrane domain of rEndo25-GFP was shortened from its C terminus to generate rEndo23, 21, 19 to 9-GFP constructs.
The rEndo9-GFP construct consists of the cytosolic tail of rEndo fused to GFP. (C) Myc-tagged rat endomannosidase lacking the whole
signal sequence (Dsig-rEndo) or the transmembrane domain (DTMD-rEndo) or the cytoplasmic tail (DCT-rEndo). (D) Myc-tagged full-
length rat endomannosidase (top row) and constructs with alterations in the cytoplasmic tail (lower rows).
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treatment of microsomes rendered it sensitive
(Fig. 2B). In contrast, engineered rEndo lacking the
cytoplasmic tail (DCT-rEndo) was sensitive to protei-
nase K (Fig. 2B), indicating the failure to acquire a
type II membrane topology. Thus, rEndo possesses a
type II membrane orientation containing a short N-
terminal cytoplasmic tail, a transmembrane domain
and a large catalytic domain situated in the lumen of
the Golgi apparatus.
The putative signal sequence of rat endomannosidase
is sufficient for Golgi localization. Signal sequence
prediction analysis of rEndo suggested a potential
signal peptidase cleavage site between amino acid 25
and 26 [26]. However, no soluble form of endoman-
nosidase was detectable (Fig. 2A), suggesting that the
signal peptide is not cleaved. Thus, the transmem-
brane domain of rat endomannosidase (rEndo25),
included in the first 25 N-terminal amino acids, might
act as membrane anchor and be responsible for Golgi
retention of endomannosidase. To test this hypothesis,
we constructed a chimeric a1-antitrypsin (rEndo25/
A1AT, Fig. 1A) containing the signal sequence of
rEndo25. When expressed in clone 9 hepatocytes
(Fig. 3A–C) or in CHO-K1 cells (data not shown),
the chimeric a1-antitrypsin showed a typical Golgi
staining and overlapped with the immunofluores-
cence for Golgi mannosidase II. In contrast, human
a1-antitrypsin expressed in clone 9 hepatocytes ex-
hibited the reported ER staining pattern (Fig. 3D–F).
Metabolic labeling showed that chimeric a1-antitryp-
sin was synthesized as a 52-kDa non-secreted glyco-
protein carrying complex-type oligosaccharides as
demonstrated by their EndoH resistance andPNGase
F sensitivity (Fig. 4). Furthermore, expression of
rEndo25 fused to theGFP (rEndo25-GFP, Fig. 1A) in
CHO-K1 cells (Fig. 3G–I), HepG2 and HeLa cells
(data not shown) resulted in Golgi localization.
Hence, the 25 N-terminal amino acids of rEndo,
which include the cytoplasmic tail and the trans-
membrane domain, appear to contain the structural
information for Golgi retention of the enzyme.
The cytoplasmic tail and transmembrane domain of
rat endomannosidase are required for its Golgi local-
ization. The Golgi localization of various glycosyl-
transferases is dependent on the length of their
hydrophobic region [15, 29]. To test whether this
observation applies to endomannosidase, various
rEndo-GFP constructs weremade, in which the length
of the transmembrane domain was shortened from its
C terminus (rEndo23, 21, 19–11-GFP, Fig. 1B) or which
were devoid of it (rEndo9-GFP, Fig. 1B). When stably
expressed in CHO-K1 cells, all studied rEndo-GFP
constructs with a signal sequence<25 amino acids, i.e. ,
a transmembrane domain with <16 amino acids,
showed a diffuse cytoplasmic staining (Fig. 5A).
Membrane and cytosolic fractions of CHO cells
expressing the various rEndo-GFP constructs were
analyzed by Western blotting. Only the rEndo25-GFP
was detectable in the membrane fraction, whereas
rEndo23-GFP, rEndo21-GFP and GFP alone were
mainly found in the cytosolic fraction (Fig. 5B) similar
to all other analyzed rEndo-GFP constructs (data not
shown). Furthermore, rEndo was Golgi-retained if its
transmembrane domain was replaced by 16 leucine
residues (Fig. 3K–M). If the length of the poly-leucine
stretch was increased to 23 leucine residues, a
vesicular staining pattern and occasionally a faint
cell surface staining was observed beside the Golgi
staining (Fig. 3N–P). Collectively, these data indicate
that the length of the transmembrane domain of
rEndo is important for Golgi localization.
Next, the importance of each domain of rEndo for
Golgi localization was evaluated. For this we gener-
Figure 2. Rat endomannosidase is a type IImembraneprotein. (A)
CHO cells stably expressing myc-tagged rat endomannosidase
were homogenized (H) (seeMaterials andmethods) and separated
into pellet (P) and supernatant (S) by centrifugation at 100 000 g
for 1 h followed by Western blotting using anti-myc antibody. (B)
Urea-stripped membranes from CHO-K1 cells stably expressing
myc-tagged rat endomannosidase (rEndo) were treated with
proteinase K (0.2 and 2 mg) in the absence or presence of 1%
Triton X-100 and analyzed by Western blotting with anti-myc
antibody. The same procedure was applied to myc-tagged rat
endomannosidase devoid of the cytoplasmic tail (DCT-rEndo).
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atedmyc-tagged rEndo constructs (Fig. 1C)where the
entire signal sequence was deleted (Dsig-rEndo), or
either the 16 amino acids of the transmembrane
domain (DTMD-rEndo) or the cytoplasmic tail (DCT-
rEndo) were missing. In CHO-K1 cells expressing
Dsig-rEndo or DTMD-rEndo, endomannosidase was
undetectable by confocal microscopy. In agreement
with this finding, no rEndo DNA fragment could be
amplified by RT-PCR using RNA from the trans-
fected CHO-K1 cells and rEndo-specific primers. On
the other hand DCT-rEndo exhibited an ER local-
ization (Fig. 6A–C) and failed to maintain a type II
membrane topology (Fig. 2B).
Positively charged amino acids in the cytoplasmic tail
of endomannosidase are not essential for Golgi local-
ization. Remarkably, vertebrate endomannosidases
and CHO-K1 cell endomannosidase [26] possess a
cluster of conserved positively charged amino acid in
their cytoplasmic tail (Table 2). To evaluate their
requirement for Golgi localization, we replaced or
deleted these residues (Fig. 1D). The myc-tagged
rEndo R5–7K exhibited a typical Golgi localization
(data not shown), similarly to a back-engineered
Cys177/Cys188Trp CHO cell endomannosidase pos-
sessing two arginine and one lysine residue at this
position [26]. Surprisingly, rEndoR5–7I (Fig. 6D–F) or
rEndo R5–7L (data not shown) also exhibited a Golgi
localization, whereas rEndo DR5–7 was ER localized
Figure 3. Endomannosidase sig-
nal sequence is sufficient for
Golgi localization of a1-antitryp-
sin and GFP. Confocal double
immunofluorescence for a1-anti-
trypsin and endogenous Golgi-
mannosidase II in clone 9 hepa-
tocytes. In a single confocal sec-
tion, rEndo25/a1-antitrypsin (A)
and Golgi mannosidase II (B)
showed co-distribution (C),
whereas wild-type human a1-an-
titrypsin (D) only partially co-
localized with Golgi mannosi-
dase II (E, F). rEndo25-GFP (G)
stably expressed in CHO-K1
cells and Golgi-mannosidase II
(H) showed co-distribution (I).
rEndo with a transmembrane
domain of 16 leucine residues,
rEndo DTMD/L16, (K) and
Golgi-mannosidase II (L)
showed co-distribution (M) in
CHO-K1 cells, whereas rEndo
with a transmembrane domain of
23 leucine residues, rEndo
DTMD/L23 (N) showeda broader
subcellular distribution (P). Bars,
10 mm.
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(data not shown). Furthermore, rEndo with a trun-
cated cytoplasmic tail possessing three arginine resi-
dues (MRRR-rEndo) showed a typical Golgi local-
ization and no ER staining was observed (Fig. 6G–I).
Moreover, rEndo with the same length of cytoplasmic
tail containing three leucine residues (MLLL-rEndo)
instead of arginines also exhibited aGolgi localization
(Fig. 6K–M). Next, specific positively amino acid
residues in the cytoplasmic tail of rEndo were either
replaced by neutral ones or completely deleted
(Table 3) to determine the contribution of each of
this charged residue for Golgi localization. The
subcellular distribution of engineered rEndo25-GFP
constructs, determined by immunofluorescence mi-
croscopy, was consistent with those of full-length rat
endomannosidase containing the corresponding mu-
tations (Table 3). Replacement of K3, or one of the
three consecutive arginine residues, e.g., R5, R6 or R7,
by leucine did not alter the inherent Golgi localization
(Table 3). Similarly, rEndo25R5–7I-GFP (Fig. 7A–C) or
rEndo25R5–7L-GFP, (Fig. 7D–F) as well as rEndo25R5–7
H-GFP (data not shown) were Golgi-retained and
maintained a type II topology (Fig. 8). Thus, the
presence of positively charged amino acids in the
cytoplasmic tail of endomannosidase is not essential
for its Golgi localization as long as the engineered
protein achieves a type II topology.
Discussion
In the present study, we have experimentally shown
that Golgi endomannosidase possesses as a type II
membrane protein architecture. Furthermore, we
have identified specific amino acids important for
correct topology and putative targeting sequences
responsible for Golgi retention of endomannosidase.
Protease protection experiments (present study) and
susceptibility against detergents [27, 30] indicated that
endomannosidase is an integral type II membrane
protein containing a short cytoplasmic tail, a single
transmembrane domain and a large, luminal-located
catalytic domain. Thus, its architecture and amino acid
composition of the transmembrane domain resemble
those of other Golgi-localized enzymes [17, 31, 32].
Our biochemical and microscopical data demonstrat-
ed that the 25 N-terminal amino acids of rat endo-
mannosidase, comprising the cytoplasmic tail and the
transmembrane domain are sufficient to retain two
reporter proteins, the secretory a1-antitrypsin or GFP
in the Golgi apparatus. Golgi retention was prevented
by reducing the length of the transmembrane domain
of endomannosidase, as reported for sialyltransferase
[15, 29] and for syntaxins [33]. On the other hand,
replacement of the transmembrane domain by 16
leucine residues resulted in Golgi localization of rat
endomannosidase, while increasing the length to 23
leucine residues reduced its Golgi retention. Thus, the
Figure 4. Intracellular retained chimeric a1-antitrypsin is carrying
complex type oligosaccharides. Clone 9 rat hepatocytes expressing
chimeric a1-antitrypsin were pulsed for 20 min and chased for the
time period indicated. Cell lysates was immunoprecipitated with
anti-human a1-antitrypsin antibody and analyzed by 8% SDS-
PAGE/fluorography. The intracellular chimeric a1-antitrypsin was
Endo H-resistant and PNGase F sensitive. The asterisks indicate
co-immuoprecipitated proteins.
Figure 5. Rat endomannosidase-GFP constructs with a shortened
signal sequence showed cytoplasmic localization. (A) CHO-K1
cells expressing GFP fused to a truncated signal sequence of
endomannosidase (rEndo23 to rEndo9) exhibited a cytoplasmic
staining similar to GFP alone. (B) CHO-K1 cells, stably expressing
GFP fused to rat endomannosidase signal sequence of various
length, were separated into amembrane (M) and cytosolic fraction
(C) by differential centrifugation (see Materials and methods) and
analyzed by Western blotting using anti-GFP antibody.
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Figure 6. Rat endomannosidase
possessing positively charged
amino acids within the cytoplas-
mic tail exhibited Golgi localiza-
tion. Confocal double immuno-
fluorescence for myc-tagged rat
endomannosidases expressed in
CHO-K1 cells and Golgi manno-
sidase II or ER marker Sec61b,
respectively. Rat endomannosi-
dase lacking the cytoplasmic tail
DCT-rEndo (A), overlapped
with Sec61b (B, C). Engineered
rat Endo R5–7I (D) and Golgi
mannosidase II (E) showed co-
distribution (F). Rat endoman-
nosidase with a truncated cyto-
plasmic tail possessing three ar-
ginines, MRRR-rEndo (G) and
Sec61b (H) did not overlap (I).
Rat endomannosidase with trun-
cated cytoplasmic tail possessing
three leucine residues instead of
arginines,MLLL-rEndo (K), and
Golgi mannosidase II (L)
showed co-distribution (M).
Bars, 10 mm.
Table 2. Highly conserved positively charged amino acids in the cytoplasmic tail of endomannosidase of various species.
Cytoplasmic taila TMD sequence Accession no.b Organism
MAKFRRRTC IILSLFIVFIFSLMMG NP_542963 Rattus norvegicus
MAKFRRRTC IILALFIVFIFSLMMG NP_078917 Homo sapiens
MAKFRRRTC IILALFILFIFSLMMG XP_001096615 Macaca mulatta
MAKFRRRTC ILLSLFILFIFSLMMG NP_766453 Mus musculus
MAKFRRRTC IILSLIILFIFSLMMG XP_539046 Canis familiaris
MAKFRRGTC IILALFILFIFSLMMG Q5RD93 Pongo pygmaeus
MARFRRRTC IILSLFILLICSLMMG XP_001377143 Monodelphis domestica
MARFRRRTC IILLLFILFICSIMMG XP_419831 Gallus gallus
MIRFRRRTC ITLSIFIFLVCLIM NP_001086682 Xenopus leavis
MAKFRRKTC IILSLFILFIFSLMMG DQ825405 Cricetulus griseus
a The positively charged amino acids in the cytoplasmic tail are in bold.
b GenBank accession number.
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length of the transmembrane domain has a major
effect in Golgi retention of the endomannosidase.
Similarly, the importance of the transmembrane
domain for the localization of other Golgi resident
enzymes has been demonstrated [29, 34–37]. Of
course, the possibility remains that the cytoplasmic
tail of endomannosidase is also involved in Golgi
retention, as reported for the Golgi retention of
fucosyltransferase [19, 32]. Collectively, we conclude
that endomannosidase Golgi retention occurs via the
bilayer thickness mechanism. This notion was further
supported by the fact that we did not obtain direct
evidence for specific interaction or kin recognition
[21] between endomannosidase and other proteins of
the cis or medial Golgi. Moreover, it was shown that
the kin recognition between enzymes of the medial
Golgi involves luminal sequences of the enzyme
rather than transmembrane domains [15, 18].
Endomannosidases from various species share as
distinguishing feature a cluster of arginine residues
in their cytoplasmic tail (Table 2). Multiple arginine
residues located at specific positions of theN terminus
Table 3. Subcellular localization rat endomannosidase25-GFP constructs with mutations in the cytoplasmic tail
a.
Constructb CT TMD Localization
rEndo25 MAKFRRRTC IILSLFIVFIFSLMMG Golgi
MRRR-rEndo25 MRRRTC IILSLFIVFIFSLMMG Golgi
DCT-rEndo25 M IILSLFIVFIFSLMMG ER
rEndo25DR5–7 MAKFTC IILSLFIVFIFSLMMG ER
rEndo25K3L MALFRRRTC IILSLFIVFIFSLMMG Golgi
rEndo25R5L MAKFLRRTC IILSLFIVFIFSLMMG Golgi
rEndo25R6L MAKFRLRTC IILSLFIVFIFSLMMG Golgi
rEndo25R7L MAKFRRLTC IILSLFIVFIFSLMMG Golgi
rEndo25R5–7I MAKIIITC IILSLFIVFIFSLMMG Golgi
rEndo25R5–7L MAKFLLLTC IILSLFIVFIFSLMMG Golgi
rEndo25R5–7H MAKFHHHTC IILSLFIVFIFSLMMG Golgi
a CT, cytoplasmic tail; TMD, transmembrane domain.
b The generation of the various rat endomannosidase-GFP constructs is described under Materials and methods.
Figure 7. Positively charged
amino acids within the cytoplas-
mic tail of rat endomannosi-
dase25-GFP are not essential for
Golgi localization. Double con-
focal immunofluorescence for
rEndo25R5–7I-GFP (A) or
rEndo25R5–7L-GFP (B) and Gol-
ACHTUNGTRENNUNGgi-ACHTUNGTRENNUNGmannosidase II (B, E) showed
overlapping distributions (C, F).
Bars 10 mm.
Figure 8. Rat endomannosidase25-GFP devoid of positively charg-
ed amino acid in the cytoplasmic tail maintains type II topology.
Urea-stripped membranes from CHO-K1 cells expressing rEndo25
R5–7I-GFP or rEndo25R5–7L-GFP were treated with proteinase K
(0.2 and 2 mg) in the absence or presence of 1% Triton X-100 and
analyzed by Western blotting with anti-GFP antibody.
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were responsible for ER targeting of some type II
membrane proteins [8, 38], similar to the double lysine
motif found at the C terminus of type I membrane
proteins [4–7]. Conversely, the localization of endo-
mannosidase, a type II membrane protein, excludes
the possibility that these arginine residues constitute
an ER-targeting motif. Thus, depending on the
position of the arginine residues within the cytoplas-
mic tail, they act as ER retention or ER export signal.
So far, a di-acidic motif located at variable distance
from C terminus of some transmembrane secretory
proteins has been proposed as an ER export signal
[39–42], whereas ER export of proteins cycling
between ER and Golgi depends on hydrophobic
residues in their cytoplasmic tail [43, 44]. More
recently, a novel type of ER export signal has been
described consisting of dibasic amino acids, located
proximal to the transmembrane domain in the cyto-
plasmic tail of Golgi-resident glycosyltransferase that
is required for type II membrane protein to exit the
ER by COPII vesicles [45]. Indeed, full-length rat
endomannosidase possesses three consecutive argi-
nine residues proximal to the transmembrane domain.
Based on our data, the arginine at position 5 and 6, 6
and 7 as well as 5 and 7 can be part of the dibasic motif.
Furthermore, the highly conserved arginine residues
in endomannosidase can be fully replaced by other
positively charged amino acids such as lysine residues
as well as a combination between arginine/lysine as
found in engineered CHO cell endomannosidase [26]
without affecting its intracellular localization. Sur-
prisingly, substitution of the positively charged amino
acid residues in the cytoplasmic tail residues by
neutral amino acids did not abolishGolgi localization.
Thus, in addition to the positive charge, the structural
information of the amino acid side chain contributes
to topology resulting in ER to Golgi transport
competence. Therefore, properly oriented mutagen-
ized proteins reach the Golgi, whereas those with
inverted topology, like the cytoplasmic tail-deleted
endomannosidase, remains in the ER.
Removal of glucose residues from the N-linked
oligosaccharides precursor occurs either by the clas-
sical trimming pathway by glucosidases or by the
alternate endomannosidase pathway. Glucosidase I is
retained in the ER by sequence motifs located in the
luminal domain [38] and glucosidase II by the so-
called b-subunit carrying the C-terminal KDEL
retrieval sequence [46–48], whereas endomannosi-
dase is retained in the Golgi by its 25 N-terminal
amino acids. Thus, distinctmechanisms ensure that the
glucose-trimming enzymes are located in different
compartments [23, 49] and fulfill specific functions.
ER-located glucosidase II is not only involved in the
biosynthesis ofN-linked oligosaccharides but is also a
key enzyme in the quality control of glycoprotein
folding [50, 51], whereas endomannosidase provides a
back-upmechanism for proteinN-glycosylation in the
Golgi apparatus [27]. Furthermore, the Golgi local-
ization of endomannosidase allows a quality control of
glycoprotein folding and assembly by the calnexin/
calreticulin cycle [51].
In summary, we elucidated the molecular structure of
endomannosidase and demonstrated that both the
cytoplasmic tail and the transmembrane domain of
endomannosidase are necessary for efficient Golgi
retention of the enzyme. The former one is required
for correct topology, whereas the latter is necessary for
the Golgi retention.
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